| Listed site | cdmo | cdmo |
|---|
| Summary | Purpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities. | US-based aseptic fill-finish CDMO specializing in parenteral biologics, peptides, and small molecules from development through commercial supply, with formulation, analytical, stability testing, and vial/syringe/cartridge filling capabilities. |
|---|
| Services | - Formulation Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Inhalation & Nasal Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Stability Testing & Storage
- Quality Control Testing
- CMC Regulatory Submission Support
- Combination Product Assembly & Final Packaging
| - Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support
|
|---|
| Modalities | Data not yet provided. | - Small Molecule
- Biologics (Other)
- Peptide
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, Woodbury, Minnesota, United States
- Bridgeton, Bridgeton, Missouri, United States
- Brentwood, Brentwood, Missouri, United States
- Maryland Heights, Maryland Heights, Maryland, United States
- Northridge, Northridge, California, United States
- Union City, Union City, California, United States
- Lexington, Lexington, Kentucky, United States
- Germantown, Germantown, Maryland, United States
- Loughborough, Loughborough, England, United Kingdom
- Clitheroe, Clitheroe, England, United Kingdom
- Bridgeton, Bridgeton
| - Headquarters, Costa Mesa, California, United States
|
|---|
| Certifications | - FDA · Identifier: cGMP (CFR 210, 211, 820; 21 CFR Part 4)
- ICH · Identifier: ICH Q1A through Q10
- EU · Identifier: Annex 1 compliance
- ISO · Identifier: ISO certifications
- FDA · Identifier: cGMP (CFR 210, CFR 211, CFR 820, 21 CFR Part 4)
- EMA · Identifier: Annex 1 Compliance
| - FDA · Identifier: cGMP-compliant
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|